Gordon Ralph Corey, MD

Professor Emeritus of Medicine
Gary Hock Distinguished Professor in Global Health, in the School of Medicine
Vice-Chair for Education and Global Health in the Department of Medicine
Professor of Pathology
Member in the Duke Clinical Research Institute
Campus mail 310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708
Phone (919) 668-7174
Email address corey001@mc.duke.edu

My research is based at the Duke Clinical Research Institute, a large academic clinical research organization designed to conduct clinical trials from small local studies to worldwide trials. The focus of my research is bacterial infections: complicated skin and skin structure infections; postoperative wound infections; hospital-acquired and ventilator-associated pneumonia; bacteremia; and endocarditis. Many of these trials are conducted in concert with the pharmaceutical industry in order to register new antibiotics. In addition, as director of infectious diseases at the DCRI I oversee the work of the mycology group, and tuberculosis trials. This work also includes work supported by NIH grants including sepsis trials, the Staph Aureus and Staph Epi Bacteremia Groups, and the International Collaboration of Endocarditis. The team of investigators with whom I work is highly experienced, amazingly productive and wonderfully collegial.

As a result of my longstanding interest in tropical medicine and the generosity of my patients as well as the Hubert Family we have been able to establish the Hubert-Yeargan Center for Global Health. As a result we have developed a medical center-wide fellowship in Global Health. I am presently the Director of the Center and the Gary Hock Distinguished Professor of Global Health.

Education and Training

  • Fellowship, Infectious Diseases, Duke University School of Medicine, 1978 - 1980
  • Chief Resident, General Internal Medicine, Duke University School of Medicine, 1977 - 1978
  • Residency, General Internal Medicine, Duke University School of Medicine, 1975 - 1977
  • Internship, General Internal Medicine, Duke University School of Medicine, 1974 - 1975
  • M.D., Baylor University, 1973


Rangwala, Fatima, Opass Putcharoen, Chureeratana Bowonwatanuwong, Nneka Edwards-Jackson, Siriluck Kramomthong, Jerome H. Kim, G Ralph Corey, and Jintanat Ananworanich. “Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review.” Southeast Asian J Trop Med Public Health 43, no. 2 (March 2012): 436–41.


Rubinstein, E., G. R. Corey, and M. E. Stryjewski. “Erratum: Reply to Tarchini (Clinical Infectious Diseases (2011) 52 (1391-1392)).” Clinical Infectious Diseases 54, no. 2 (January 15, 2012): 309. https://doi.org/10.1093/cid/cir853.

Full Text

Rubinstein, Ethan, G Ralph Corey, Martin E. Stryjewski, and Zeina A. Kanafani. “Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia.” Expert Opin Pharmacother 12, no. 17 (December 2011): 2737–50. https://doi.org/10.1517/14656566.2011.633511.

Full Text

Nienaber, Juhsien J. C., Batu K. Sharma Kuinkel, Michael Clarke-Pearson, Supaporn Lamlertthon, Lawrence Park, Thomas H. Rude, Steve Barriere, et al. “Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins.” J Infect Dis 204, no. 5 (September 1, 2011): 704–13. https://doi.org/10.1093/infdis/jir389.

Full Text